Danaher (DHR) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
Danaher Corporation (DHR) insider buying and selling: no purchases, 11 sales
81 Form 4 Table I transactions filed with the SEC by Danaher Corporation insiders between 2025-08-25 and 2026-10-14 (15-month history): 0 open-market purchases and 11 sales, plus 70 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a sale of $129.6M by Rales Mitchell P on 2025-10-31.
Danaher insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, Danaher insiders filed 10 sales worth $257.9M on the open market, and no purchases.
The biggest seller was Rales Mitchell P (Chairman of Exec. Committee): $234.6M in 3 sales, out of 8 different sellers.
The largest trade of the period was a sale of $129.6M on Oct 31, 2025, by Rales Mitchell P (Chairman of Exec. Committee). Form 4 on sec.gov (0001193125-25-264810).
None of the 10 sales carries the 10b5-1 plan flag on the Form 4 (sales scheduled months ahead).
The last three months show 1 sale, against 1 in the three before. The latest sale from Aug 21, 2026.
Against its sector (Healthcare, 59 companies with an insider page on this site), over the same dates the median is 9 sales and 0 purchases on the open market. Danaher has more sales than 31 of the other 58, ranks 5 of 59 by net dollars sold, and 19 of the 59 have at least one purchase.
The 20 most important trades
With no open-market purchases, the table starts with DHR's sales, largest first. The full history is in the tool above, already searched.
See all 81 DHR trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2025-10-31 | 2025-11-04 | Rales Mitchell P | Chairman of Exec. Committee | $129.6M | S — Open-market sale3 Form 4 footnotesF1 The price reported in Column 4 represents a weighted average sales price of $215.67. These shares were sold in multiple transactions at prices ranging from $215.00 to $215.99, inclusive. The reporting person undertakes to provide to Danaher Corp., any security holder of Danaher Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 1 through 3 of this Form 4. F2 The price reported in Column 4 represents a weighted average sales price of $216.26. These shares were sold in multiple transactions at prices ranging from $216.00 to $216.99, inclusive. F3 The price reported in Column 4 represents a weighted average sales price of $217.17. These shares were sold in multiple transactions at prices ranging from $217.00 to $217.66, inclusive. | SEC |
| 2025-11-12 | 2025-11-13 | Rales Mitchell P | Chairman of Exec. Committee | $95.6M | S — Open-market sale4 Form 4 footnotesF1 The price reported in Column 4 represents a weighted average sales price of $217.64. These shares were sold in multiple transactions at prices ranging from $216.92 to $217.915, inclusive. The reporting person undertakes to provide to Danaher Corp., any security holder of Danaher Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 1 through 4 of this Form 4. F2 The price reported in Column 4 represents a weighted average sales price of $218.27. These shares were sold in multiple transactions at prices ranging from $217.92 to $218.905, inclusive. F3 The price reported in Column 4 represents a weighted average sales price of $219.43. These shares were sold in multiple transactions at prices ranging from $218.935 to $219.93, inclusive. F4 The price reported in Column 4 represents a weighted average sales price of $220.15. These shares were sold in multiple transactions at prices ranging from $219.935 to $220.33, inclusive. | SEC |
| 2026-08-21 | 2026-08-24 | Blair Rainer | President & CEO | $12.7M | S — Open-market sale Indirect holding, through: By Trust 3 Form 4 footnotesF1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.21 to $218.205, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.21 to $219.20, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.2275 to $219.945, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | SEC |
| 2025-11-25 | 2025-11-26 | Rales Mitchell P | Chairman of Exec. Committee | $9.4M | S — Open-market sale Indirect holding, through: Through the Mitchell P. Rales Family Trust 3 Form 4 footnotesF1 The price reported in Column 4 represents a weighted average sales price of $230.27. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.95, inclusive. The reporting person undertakes to provide to Danaher Corp., any security holder of Danaher Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. F2 The Reporting Person is the trustee of the Mitchell P. Rales Family Trust. F3 The price reported in Column 4 represents a weighted average sales price of $231.19. These shares were sold in multiple transactions at prices ranging from $231.00 to $231.44, inclusive. The reporting person undertakes to provide to Danaher Corp., any security holder of Danaher Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. | SEC |
| 2025-11-12 | 2025-11-13 | Ellis Brian W | Senior Vice President - GC | $4.8M | S — Open-market saleForm 4 footnoteF1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.110 to $219.410, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | SEC |
| 2025-11-11 | 2025-11-13 | Mcgrew Matthew | EVP & Chief Financial Officer | $3.5M | S — Open-market saleForm 4 footnoteF1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.580 to $214.810, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | SEC |
| 2025-11-10 | 2025-11-12 | Couchara Georgeann | SVP, Human Resources | $1.1M | S — Open-market saleForm 4 footnoteF1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.4101 to $210.570, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | SEC |
| 2025-11-18 | 2025-11-19 | List Teri | Director | $747k | S — Open-market sale | SEC |
| 2025-08-22 | 2025-08-25 | List Teri | Director | $586k | S — Open-market sale | SEC |
| 2026-02-19 | 2026-02-20 | Milosevich Gregory M | Executive Vice President | $275k | S — Open-market sale | SEC |
| 2026-05-01 | 2026-05-04 | Spoon Alan G | Director | $237k | S — Open-market saleForm 4 footnoteF1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.67 to $174.72, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | SEC |
| 2026-02-02 | 2026-02-04 | Blair Rainer | President & CEO | $1.7M | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 This transaction relates to the withholding of certain shares for tax purposes in connection with the distribution of performance-based restricted stock units. | SEC |
| 2025-11-12 | 2025-11-13 | Ellis Brian W | Senior Vice President - GC | $1.3M | M — Option exercise | SEC |
| 2025-11-11 | 2025-11-13 | Mcgrew Matthew | EVP & Chief Financial Officer | $1.0M | M — Option exercise | SEC |
| 2026-02-02 | 2026-02-04 | Mcgrew Matthew | EVP & Chief Financial Officer | $415k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 This transaction relates to the withholding of certain shares for tax purposes in connection with the distribution of performance-based restricted stock units. | SEC |
| 2025-11-10 | 2025-11-12 | Couchara Georgeann | SVP, Human Resources | $368k | M — Option exercise | SEC |
| 2025-11-15 | 2025-11-18 | Gray R Bradley | SVP Strategic Development | $310k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-02-02 | 2026-02-04 | Ellis Brian W | Senior Vice President - GC | $280k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 This transaction relates to the withholding of certain shares for tax purposes in connection with the distribution of performance-based restricted stock units. | SEC |
| 2026-07-15 | 2026-07-16 | Zerhouni Elias A. | Director | $237k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-07-15 | 2026-07-16 | Filler Linda | Director | $237k | F — Tax withholding (shares surrendered for taxes) | SEC |
The period balance: money in, money out
In the Form 4 filings submitted between Aug 25, 2025 and Oct 14, 2026 there is not one open-market purchase of Danaher Corporation: 11 sales worth $258.5M and zero dollars bought.
Only codes P and S count, where an insider puts in or takes out their own money. A selling balance like Danaher Corporation's is the norm in the S&P 500, where much of the pay comes as stock. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| A | Grant or award | 33 | $0 |
| F | Tax withholding (shares surrendered for taxes) | 25 | $4.6M |
| S | Open-market sale | 11 | $258.5M |
| M | Option exercise | 8 | $3.7M |
| D | Sale back to the issuer | 2 | $0 |
| G | Gift | 2 | $0 |
| Total | Everything filed in the period | 81 | $266.8M |
37 of the 81 rows carry no usable amount on the Form 4: they count as trades and add $0. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 22 distinct people or entities have filed Danaher Corporation transactions: none bought on the open market and 8 sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
Of the 8 who sold on the open market (11 sales in all), the three biggest sellers account for $252.1M of the $258.5M: 98% of the money in three people.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Rales Mitchell P | Chairman of Exec. Committee | 7 | — | $234.6M (3) | 2026-10-14 |
| Blair Rainer | President & CEO | 4 | — | $12.7M (1) | 2026-08-24 |
| Ellis Brian W | Senior Vice President | 4 | — | $4.8M (1) | 2026-02-06 |
| Mcgrew Matthew | Executive Vice President | 5 | — | $3.5M (1) | 2026-03-03 |
| List Teri | Director | 4 | — | $1.3M (2) | 2026-05-19 |
| Couchara Georgeann | SVP, Human Resources | 7 | — | $1.1M (1) | 2026-05-19 |
| Milosevich Gregory M | Executive Vice President | 8 | — | $275k (1) | 2026-08-06 |
| Spoon Alan G | Director | 3 | — | $237k (1) | 2026-05-19 |
Shown here are the 8 who moved the most money, out of 22. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
By the month the trade was executed, not the month it was filed; months with no trades show zero. The busiest month was Nov 2025: 0 purchases and 6 sales, worth $115.0M. 9 of the 15 months have none.
| Month | Purchases | Amount | Sales | Amount |
|---|---|---|---|---|
| Aug 2025 | 0 | $0 | 1 | $586k |
| Sep 2025 | 0 | $0 | 0 | $0 |
| Oct 2025 | 0 | $0 | 1 | $129.6M |
| Nov 2025 | 0 | $0 | 6 | $115.0M |
| Dec 2025 | 0 | $0 | 0 | $0 |
| Jan 2026 | 0 | $0 | 0 | $0 |
| Feb 2026 | 0 | $0 | 1 | $275k |
| Mar 2026 | 0 | $0 | 0 | $0 |
| Apr 2026 | 0 | $0 | 0 | $0 |
| May 2026 | 0 | $0 | 1 | $237k |
| Jun 2026 | 0 | $0 | 0 | $0 |
| Jul 2026 | 0 | $0 | 0 | $0 |
| Aug 2026 | 0 | $0 | 1 | $12.7M |
| Sep 2026 | 0 | $0 | 0 | $0 |
| Oct 2026 | 0 | $0 | 0 | $0 |
The last month may be partial: a Form 4 is filed up to two business days later. The table does not say whether the pattern is good or bad; it says when it happened.
Danaher Corporation (DHR) analysis page →
Other Healthcare companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
None of the 11 sales in the table is flagged as scheduled (10b5-1 plan), the kind signed months ahead and executed automatically. Danaher has no open-market purchase (code P) in the history, the most common case in the S&P 500: insiders are already paid in stock. The latest filing is from Oct 14, 2026, and a Form 4 arrives up to two business days after the trade.
11 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.